Search research articles
Contact Us
Filters
Showing results (521-530 of 608) with videos related to
Page
of 61
Sort By:
American Journal of Clinical Oncology
|
February 20, 1999
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer
R F Marschke, J P Grill, J A Sloan, et al.
Leukemia
|
September 10, 2004
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
P H Wiernik, E Paietta, O Goloubeva, et al.
Acta Virologica
|
December 19, 2014
Emergence of Val27Ala mutation in M2 protein associated with amantadine resistance in highly pathogenic avian influenza H5N1 viruses in India
C Tosh, S Nagarajan, H V Murugkar, et al.
American Journal of Clinical Oncology
|
October 20, 2000
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial
P A Burch, C Ghosh, G Schroeder, et al.
Blood
|
June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides
J W Lynch, I Linoilla, E A Sausville, et al.
Current Oncology (Toronto, Ont.)
|
September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications
Servando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1995
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial
R M Goldberg, C L Loprinzi, J A Mailliard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome
F M Foss, D C Ihde, D L Breneman, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
Combined multiphoton microscopy and somatostatin receptor type 2 imaging of pancreatic neuroendocrine tumors
Noelle Daigle, Thomas Knapp, Suzann Duan, et al.
Plos One
|
October 27, 2015
Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation
Anil K Singh, Sumit Rathore, Yan Tang, et al.
Page
of 61
Search research articles
Search
Showing results (521-530 of 608) with videos related to
Sort By:
Page
of 61
American Journal of Clinical Oncology
|
February 20, 1999
Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer
R F Marschke, J P Grill, J A Sloan, et al.
Leukemia
|
September 10, 2004
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
P H Wiernik, E Paietta, O Goloubeva, et al.
Acta Virologica
|
December 19, 2014
Emergence of Val27Ala mutation in M2 protein associated with amantadine resistance in highly pathogenic avian influenza H5N1 viruses in India
C Tosh, S Nagarajan, H V Murugkar, et al.
American Journal of Clinical Oncology
|
October 20, 2000
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial
P A Burch, C Ghosh, G Schroeder, et al.
Blood
|
June 25, 1992
Prognostic implications of evaluation for lymph node involvement by T-cell antigen receptor gene rearrangement in mycosis fungoides
J W Lynch, I Linoilla, E A Sausville, et al.
Current Oncology (Toronto, Ont.)
|
September 26, 2025
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications
Servando Hernandez Vargas, Solmaz Aghaamiri, Jack T Adams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1995
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial
R M Goldberg, C L Loprinzi, J A Mailliard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1992
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome
F M Foss, D C Ihde, D L Breneman, et al.
Biorxiv : the Preprint Server for Biology
|
February 13, 2023
Combined multiphoton microscopy and somatostatin receptor type 2 imaging of pancreatic neuroendocrine tumors
Noelle Daigle, Thomas Knapp, Suzann Duan, et al.
Plos One
|
October 27, 2015
Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation
Anil K Singh, Sumit Rathore, Yan Tang, et al.
Page
of 61